Compound information
- Natural Products
- ZC1826175
- Molecular Formula
- C18H19F3N4O
- Molecular Weight
- 364.151095888 g/mol
- Structure
-
- IUPAC Name
- 4-(3-pyridylmethyl)-N-[3-(trifluoromethyl)phenyl]piperazine-1-carboxamide
- InChI
- InChI=1S/C18H19F3N4O/c19-18(20,21)15-4-1-5-16(11-15)23-17(26)25-9-7-24(8-10-25)13-14-3-2-6-22-12-14/h1-6,11-12H,7-10,13H2,(H,23,26)
- InChI Key
- WGOOPKOSMUDNKK-UHFFFAOYSA-N
- SMILES
- O=C(Nc1cccc(C(F)(F)F)c1)N1CCN(Cc2cccnc2)CC1
- Source
- ZINC000013324369
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.599 |
LogS | -2.912 | LogD | 3.378 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.867 | Pgp substrate | 0.915 |
HIA | 0.963 | F20 % | 0.948 |
F30 % | 0.965 | Caco-2 | -5.046 |
MDCK | -4.824 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.725 | PPB | 89.544 |
VD | 1.733 | Fu | 0.966 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.653 | CYP1A2 substrate | 0.766 |
CYP2A6 substrate | 0.761 | CYP2B6 substrate | 0.621 |
CYP2C19 inhibitor | 0.96 | CYP2C19 substrate | 0.881 |
CYP2C8 substrate | 0.734 | CYP2C9 inhibitor | 0.898 |
CYP2C9 substrate | 0.15 | CYP2D6 inhibitor | 0.961 |
CYP2D6 substrate | 0.988 | CYP2E1 substrate | 0.777 |
CYP3A4 inhibitor | 0.618 | CYP3A4 substrate | 0.993 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.33 | CL | 11.754 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.862 | Hepatotoxicity | 0.764 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.896 |
FDAMDD | 0.831 | Skin Sensitization | 0.995 |
Carcinogenicity | 0.024 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.98 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.926 | IGC50 | 3.012 |
LC50FM | -0.492 | LC50DM | -0.166 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.454 | NR-AR-LBD | 0.224 |
NR-AhR | 0.752 | NR-Aromatase | 0.104 |
NR-ER | 0.313 | NR-ER-LBD | 0.313 |
NR-PPAR-gamma | 0.162 | SR-ARE | 0.868 |
SR-ATAD5 | 0.395 | SR-HSE | 0.14 |
SR-MMP | 0.028 | SR-p53 | 0.116 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.